Majid Sadeghizadeh

Prof. Dr. Majid Sadeghizadeh


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 2015 in Phytomedicine
Verified
Journal Article
Closed access
MZMina Zamani
Mina Zamani
MSMajid Sadeghizadeh
Majid Sadeghizadeh
MBMehrdad Behmanesh
Mehrdad Behmanesh
FNFarhood Najafi
Farhood Najafi

30 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FMFatemeh Mottaghitalab
Fatemeh Mottaghitalab
MFMehdi Farokhi
Mehdi Farokhi
AZArash Zaminy
Arash Zaminy
MKMehrdad Kokabi
Mehrdad Kokabi
MSMasoud Soleimani
Masoud Soleimani
MSMajid Sadeghizadeh
Majid Sadeghizadeh
As a contribution to the functionality of nerve guide conduits (NGCs) in nerve tissue engineering, here we report a conduit processing technique through introduction and evaluation of topographical, physical and chemical cues. Porous structure of NGCs based on freeze-dried silk/single walled carbon nanotubes (SF/SWNTs) has shown a uniform chemical and physical structure with suitable electrical conductivity. Moreover, fibronectin (FN) containing nanofibers within the structure of SF/SWNT conduits produced through electrospinning process have shown aligned fashion with appropriate porosity and diameter. Moreover, fibronectin remained its bioactivity and influenced the adhesion and growth of U373 cell lines. The conduits were then implanted to 10 mm left sciatic nerve defects in rats. The histological assessment has shown that nerve regeneration has taken places in proximal region of implanted nerve after 5 weeks following surgery. Furthermore, nerve conduction velocities (NCV) and more myelinated axons were observed in SF/SWNT and SF/SWNT/FN groups after 5 weeks post implantation, indicating a functional recovery for the injured nerves. With immunohistochemistry, the higher S-100 expression of Schwann cells in SF/SWNT/FN conduits in comparison to other groups was confirmed. In conclusion, an oriented conduit of biocompatible SF/SWNT/FN has been fabricated with acceptable structure that is particularly applicable in nerve grafts.

23 January 2013 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SBSadegh Babashah
Sadegh Babashah
MSMajid Sadeghizadeh
Majid Sadeghizadeh
AHAbbas Hajifathali
Abbas Hajifathali
MTMostafa Rezaei Tavirani
Mostafa Rezaei Tavirani
MZMina Soufi Zomorod
Mina Soufi Zomorod
MSMasoud Soleimani
Masoud Soleimani
Aberrant expression and function of microRNAs (miRNAs) in leukemia have added a new layer of complexity to the understanding of development and progression of the disease state. However, their targeting of specific signaling pathways responsible for the maintenance and survival properties of leukemic stem cell (LSC) still remains to be further clarified. Hedgehog (Hh) signaling, a highly conserved developmental pathway, has been proven as a functional pathway for LSCs, and loss of this pathway impairs the development of BCR‐ABL‐induced chronic myeloid leukemia (CML) and depletes CML stem cells. Here, we revealed that upregulation of the Hh smoothened (Smo) signal transducer was associated with reduced expression of miR‐326 in the CD34+ cells from a group of patients with CML at diagnosis. Additionally, overexpression of miR‐326 led to downregulation of Smo, resulted in decreased cell proliferation and elevated rate of apoptosis in CML CD34+ cells. Interestingly, restoration of Smo expression levels reversed the effect of miR‐326 and rescued K562 cells from the antiproliferative effects of this miRNA. Thus, Smo appears to be an essential target of miR‐326 during the pathogenesis of CML. These findings lead us to suggest that downregulation of miR‐326 may be a possible mechanism for unrestricted activation of Smo signal transducer of the oncogenic Hh pathway in CML; therefore, the restoration of miR‐326 expression could be of benefit in eradicating CD34+ CML stem/progenitor cells that represent a potential source of relapse in patients suffering CML.

14 October 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
NJNazli Jafarzadeh
Nazli Jafarzadeh
ZSZohreh Safari
Zohreh Safari
MPMajid Pornour
Majid Pornour
NANaser Amirizadeh
Naser Amirizadeh
MMMehdi Forouzandeh Moghadam
Mehdi Forouzandeh Moghadam
MSMajid Sadeghizadeh
Majid Sadeghizadeh

20 January 2021 in Frontiers in Chemistry
Verified
Journal Article
Open access
FHFadak Howaili
Fadak Howaili
EÖEzgi Özliseli
Ezgi Özliseli
BKBerrin Küçüktürkmen
Berrin Küçüktürkmen
SRSeyyede Mahboubeh Razavi
Seyyede Mahboubeh Razavi
MSMajid Sadeghizadeh
Majid Sadeghizadeh
Jessica M. RosenholmJessica M. Rosenholm
Jessica M. Rosenholm
Nanogels (Ng) are crosslinked polymer-based hydrogel nanoparticles considered to be next-generation drug delivery systems due to their superior properties, including high drug loading capacity, low toxicity, and stimuli responsiveness. In this study, dually thermo-pH-responsive plasmonic nanogel (AuNP@Ng) was synthesized by grafting poly (N-isopropyl acrylamide) (PNIPAM) to chitosan (CS) in the presence of a chemical crosslinker to serve as a drug carrier system. The nanogel was further incorporated with gold nanoparticles (AuNP) to provide simultaneous drug delivery and photothermal therapy (PTT). Curcumin's (Cur) low water solubility and low bioavailability are the biggest obstacles to effective use of curcumin for anticancer therapy, and these obstacles can be overcome by utilizing an efficient delivery system. Therefore, curcumin was chosen as a model drug to be loaded into the nanogel for enhancing the anticancer efficiency, and further, its therapeutic efficiency was enhanced by PTT of the formulated AuNP@Ng. Thorough characterization of Ng based on CS and PNIPAM was conducted to confirm successful synthesis. Furthermore, photothermal properties and swelling ratio of fabricated nanoparticles were evaluated. Morphology and size measurements of nanogel were determined by transmission electron microscopy (TEM), scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX). Nanogel was found to have a hydrodynamic size of ~167 nm and exhibited sustained release of curcumin up to 72 h with dual thermo-pH responsive drug release behavior, as examined under different temperature and pH conditions. Cytocompatibility of plasmonic nanogel was evaluated on MDA-MB-231 human breast cancer and non-tumorigenic MCF 10A cell lines, and the findings indicated the nanogel formulation to be cytocompatible. Nanoparticle uptake studies showed high internalization of nanoparticles in cancer cells when compared with non-tumorigenic cells and confocal microscopy further demonstrated that AuNP@Ng were internalized into the MDA-MB-231 cancer cells via endosomal route. In vitro cytotoxicity studies revealed dose-dependent and time-dependent drug delivery of curcumin loaded AuNP@Ng/Cur. Furthermore, the developed nanoparticles showed an improved chemotherapy efficacy when irradiated with near-infrared (NIR) laser (808 nm) in vitro. This work revealed that synthesized plasmonic nanogel loaded with curcumin (AuNP@Ng/Cur) can act as stimuli-responsive nanocarriers, having potential for dual therapy i.e., delivery of hydrophobic drug and photothermal therapy.